Kiniksa Pharmaceuticals, Ltd. ( KNSA) - Key Metrics
KNSA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.72 | $0.19 | $0.73 | $0.72 |
| 2025Q3 | $2.46 | $0.25 | $0.46 | $0.45 |
| 2025Q2 | $2.14 | $0.24 | $0.38 | $0.38 |
| 2025Q1 | $1.90 | $0.12 | $0.31 | $0.31 |
KNSA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 53.89 |
| 2025Q3 | ? | 38.76 |
| 2025Q2 | ? | 28.49 |
| 2025Q1 | ? | 47.24 |
KNSA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.36% | ? |
| 2025Q4 | 1.74% | ? |
| 2025Q3 | 1.15% | ? |
| 2025Q2 | 1.37% | ? |
| 2025Q1 | 1.38% | ? |
KNSA
Price: $48.42
52 week price:
Earnings Per Share: 0.95 USD
P/E Ratio: 60.65
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Bermuda
Volume: 221500
Market Capitalization: 4.3 billion